18F-FDG PET/CT breast cancer disease-free survival semiquantitative parameters volume-based parameters

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 May 2023
Historique:
received: 10 03 2023
revised: 02 05 2023
accepted: 09 05 2023
medline: 22 6 2023
pubmed: 22 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

We investigated whether baseline [

Identifiants

pubmed: 37345052
pii: cancers15102715
doi: 10.3390/cancers15102715
pmc: PMC10216747
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Indian J Nucl Med. 2021 Oct-Dec;36(4):385-390
pubmed: 35125756
Radiol Bras. 2021 Sep-Oct;54(5):289-294
pubmed: 34602663
Ann Oncol. 2020 Jan;31(1):61-71
pubmed: 31912797
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Front Oncol. 2022 Jun 22;12:820968
pubmed: 35814391
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):426-35
pubmed: 21057787
Clin Nucl Med. 2012 May;37(5):467-74
pubmed: 22475896
Semin Cancer Biol. 2022 Aug;83:556-569
pubmed: 33035656
Int J Mol Sci. 2022 Nov 02;23(21):
pubmed: 36362190
Breast Dis. 2022;41(1):427-432
pubmed: 36591651
Oncotarget. 2017 Jan 3;8(1):1737-1743
pubmed: 27974685
Cancer Imaging. 2021 Sep 27;21(1):55
pubmed: 34579791
Cancers (Basel). 2022 Nov 29;14(23):
pubmed: 36497351
Radiol Bras. 2019 Sep-Oct;52(5):299-304
pubmed: 31656346
Semin Nucl Med. 2022 Sep;52(5):508-519
pubmed: 35636977
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1304-11
pubmed: 23632960
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1371-7
pubmed: 25947575
J Am Coll Surg. 1995 Mar;180(3):297-306
pubmed: 7874340
Dis Markers. 2018 May 02;2018:9863092
pubmed: 29854028
Breast Cancer Res. 2017 Jan 5;19(1):3
pubmed: 28057031
Nucl Med Commun. 2022 Feb 1;43(2):212-219
pubmed: 35022378
J Natl Cancer Inst. 2022 Mar 8;114(3):391-399
pubmed: 34747484
Ir J Med Sci. 2022 Dec;191(6):2501-2510
pubmed: 35076871
Endocr Relat Cancer. 2015 Dec;22(6):T161-76
pubmed: 26206777
Mol Imaging Biol. 2019 Feb;21(1):1-10
pubmed: 29516387
Curr Med Imaging. 2023;19(8):807-816
pubmed: 35352652
Eur J Surg Oncol. 2019 Dec;45(12):2289-2294
pubmed: 31787153
Recent Results Cancer Res. 2020;216:625-667
pubmed: 32594401
Nat Rev Clin Oncol. 2015 Mar;12(3):147-62
pubmed: 25668732
Nucl Med Commun. 2017 Jun;38(6):537-545
pubmed: 28410290
Clin Med Insights Oncol. 2014 Sep 11;8:107-11
pubmed: 25249766
EJNMMI Res. 2023 Jan 23;13(1):5
pubmed: 36689007
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
Anticancer Res. 2018 Dec;38(12):6639-6652
pubmed: 30504372
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Arch Pathol Lab Med. 2014 Aug;138(8):1048-52
pubmed: 25076293

Auteurs

Natale Quartuccio (N)

Nuclear Medicine Unit, Ospedali Riuniti Villa Sofia-Cervello, 90144 Palermo, Italy.
Nuclear Medicine Unit, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, 90127 Palermo, Italy.

Pierpaolo Alongi (P)

Nuclear Medicine Unit, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, 90127 Palermo, Italy.

Luca Urso (L)

Nuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44124 Cona, Italy.

Naima Ortolan (N)

Nuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44124 Cona, Italy.

Francesca Borgia (F)

Nuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44124 Cona, Italy.

Mirco Bartolomei (M)

Nuclear Medicine Unit, Oncological Medical and Specialist Department, University Hospital of Ferrara, 44124 Cona, Italy.

Gaspare Arnone (G)

Nuclear Medicine Unit, A.R.N.A.S. Ospedali Civico, Di Cristina e Benfratelli, 90127 Palermo, Italy.

Laura Evangelista (L)

Department of Medicine DIMED, University of Padua, 35128 Padua, Italy.

Classifications MeSH